Humana Management

Management Kriterienprüfungen 4/4

Humana's CEO ist Bruce Broussard , ernannt in Jan 2013, hat eine Amtszeit von 11.42 Jahren. Die jährliche Gesamtvergütung beträgt $16.33M , bestehend aus 9% Gehalt und 91% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.073% der Aktien des Unternehmens, im Wert von $30.88M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 3 Jahre bzw. 4.3 Jahre.

Wichtige Informationen

Bruce Broussard

Geschäftsführender

US$16.3m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	9.0%
Amtszeit als Geschäftsführer	11.4yrs
Eigentum des Geschäftsführers	0.07%
Durchschnittliche Amtszeit des Managements	3yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder	4.3yrs

Jüngste Management Updates

Recent updates

Humana Inc.'s (NYSE:HUM) Intrinsic Value Is Potentially 92% Above Its Share Price

Sep 21

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Bruce Broussard im Vergleich zu den Einnahmen von Humana verändert?
Datum	Gesamtvergütung	Gehalt	Unternehmensgewinne
Mar 31 2024	n/a	n/a	US$2b
Dec 31 2023	US$16m	US$1m	US$2b
Sep 30 2023	n/a	n/a	US$3b
Jun 30 2023	n/a	n/a	US$3b
Mar 31 2023	n/a	n/a	US$3b
Dec 31 2022	US$17m	US$1m	US$3b
Sep 30 2022	n/a	n/a	US$3b
Jun 30 2022	n/a	n/a	US$3b
Mar 31 2022	n/a	n/a	US$3b
Dec 31 2021	US$17m	US$1m	US$3b
Sep 30 2021	n/a	n/a	US$3b
Jun 30 2021	n/a	n/a	US$2b
Mar 31 2021	n/a	n/a	US$4b
Dec 31 2020	US$16m	US$1m	US$3b
Sep 30 2020	n/a	n/a	US$4b
Jun 30 2020	n/a	n/a	US$4b
Mar 31 2020	n/a	n/a	US$3b
Dec 31 2019	US$17m	US$1m	US$3b
Sep 30 2019	n/a	n/a	US$3b
Jun 30 2019	n/a	n/a	US$3b
Mar 31 2019	n/a	n/a	US$2b
Dec 31 2018	US$16m	US$1m	US$2b
Sep 30 2018	n/a	n/a	US$2b
Jun 30 2018	n/a	n/a	US$1b
Mar 31 2018	n/a	n/a	US$2b
Dec 31 2017	US$20m	US$1m	US$2b

Vergütung im Vergleich zum Markt: BruceDie Gesamtvergütung ($USD16.33M) liegt im Durchschnitt der Unternehmen ähnlicher Größe auf dem Markt US ($USD13.52M).

Entschädigung vs. Einkommen: BruceDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.

Geschäftsführer

Bruce Broussard (62 yo)

11.4yrs

Amtszeit

US$16,327,384

Vergütung

Mr. Bruce Dale Broussard has been Independent Director at HP Inc. since 2021. He serves as the Member of Advisory Board of HealthQuest Capital. Mr. Bruce serves as the President and Chief Executive Officer...

Führungsteam

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Bruce Broussard	CEO & Director	11.4yrs	US$16.33m	0.073% $ 31.9m
Susan Diamond	Chief Financial Officer	3yrs	US$4.73m	0.0070% $ 3.1m
Joseph Ventura	Chief Legal Officer	5.3yrs	US$3.10m	0.0060% $ 2.6m
George Renaudin	President of Medicare & Medicaid	1.3yrs	US$3.11m	0.0024% $ 1.0m
Sanjay Shetty	President of CenterWell	1.3yrs	US$4.58m	0.00014% $ 60.9k
James Rechtin	President & COO	less than a year	keine Daten	0.000010% $ 4.4k
John-Paul Felter	Senior VP	1.8yrs	keine Daten	0.00019% $ 82.7k
Eric Tagliere	Senior VP & CTO	less than a year	keine Daten	keine Daten
Samir Deshpande	Chief Information Officer	3.4yrs	keine Daten	0.010% $ 4.5m
Timothy Huval	Chief Administrative Officer	4.9yrs	US$3.73m	0.0061% $ 2.7m
Lisa Stoner	Vice President of Investor Relations	no data	keine Daten	keine Daten
Vishal Agrawal	Chief Strategy & Corporate Development Officer	5.5yrs	keine Daten	0.0090% $ 3.9m

3.0yrs

Durchschnittliche Betriebszugehörigkeit

51.5yo

Durchschnittliches Alter

Erfahrenes Management: HUMDas Führungsteam des Unternehmens gilt als erfahren (3 Jahre durchschnittliche Betriebszugehörigkeit).

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Bruce Broussard	CEO & Director	11.4yrs	US$16.33m	0.073% $ 31.9m
Kurt Hilzinger	Independent Chairman of the Board	20.9yrs	US$601.30k	0.016% $ 7.0m
Karen Katz	Independent Director	4.8yrs	US$346.55k	0.00049% $ 213.2k
Frank D'Amelio	Independent Director	20.8yrs	US$363.55k	0.017% $ 7.4m
Jorge Mesquita	Independent Director	3.3yrs	US$351.59k	0.0018% $ 774.5k
Brad Smith	Independent Director	1.8yrs	US$311.07k	0.00032% $ 139.2k
Wayne Frederick	Independent Director	4.3yrs	US$364.87k	0.00037% $ 161.0k
David Feinberg	Independent Director	2.3yrs	US$321.52k	0.00037% $ 161.0k
Marcy Klevorn	Independent Director	3.3yrs	US$351.94k	0.00036% $ 156.6k
John Garratt	Independent Director	4.3yrs	US$326.03k	0.0010% $ 452.5k
RaQuel Bono	Independent Director	3.8yrs	US$345.03k	0.00033% $ 143.6k

4.3yrs

Durchschnittliche Betriebszugehörigkeit

62yo

Durchschnittliches Alter

Erfahrener Vorstand: HUMDie Vorstandsmitglieder gelten als erfahren (4.3 Jahre durchschnittliche Amtszeit).

Humana Management

Management Kriterienprüfungen 4/4

Wichtige Informationen

Jüngste Management Updates

Humana Inc., Annual General Meeting, Apr 18, 2024

Humana Inc., Annual General Meeting, Apr 18, 2024

President exercised options and sold US$1.3m worth of stock

Humana Inc. Announces Management Changes

Chief Financial Officer recently sold US$415k worth of stock

Chief Financial Officer notifies of intention to sell stock

Recent updates

Humana Inc. to Report Q2, 2024 Results on Jul 31, 2024

Humana: Medicare Advantage Will Never Be As Profitable As It Was

Humana (NYSE:HUM) Is Due To Pay A Dividend Of $0.885

Humana (NYSE:HUM) Will Pay A Dividend Of $0.885

Gainey Mckenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Humana, Inc

Humana Is Set Up For Long-Term Success

Humana (NYSE:HUM) Has Affirmed Its Dividend Of $0.885

First quarter 2024 earnings: EPS in line with analyst expectations despite revenue beat

Humana Inc. Revises Earnings Guidance for the Year Ending December 31, 2024

Humana (NYSE:HUM) Is Paying Out A Dividend Of $0.885

Dividend of US$0.89 announced

Here's Why Humana (NYSE:HUM) Can Manage Its Debt Responsibly

Humana Inc. Declares Cash Dividend, Payable on July 26, 2024

Humana Inc. to Report Q1, 2024 Results on Apr 24, 2024

Humana: Where To Buy This

Humana: This Year's Drop Might Have Created A Buying Opportunity

Humana Inc., Annual General Meeting, Apr 18, 2024

Humana Inc., Annual General Meeting, Apr 18, 2024

Humana Inc. Declares Cash Dividend, Payable on April 26, 2024

Humana: A Golden Buying Opportunity As Fears Potentially Peaked

Humana Inc. Provides Earnings Guidance for 2024

Humana: The $300 Level Could Get Taken Out In The Near Future

Humana Announces Limited Layoffs

Humana: My Oh My, Another Strong Buy

Humana: Buy This Powerful Dividend Growth Stock In The New Year

Upcoming dividend of US$0.89 per share at 0.8% yield

President exercised options and sold US$1.3m worth of stock

Does Humana (NYSE:HUM) Have A Healthy Balance Sheet?

Humana: Failed Merger And Other Reasons To Buy

Cigna Reportedly Ends Humana Merger Talks

Cigna, Humana Reportedly in Talks for Merger

Humana Inc. Declares Cash Dividend, Payable on January 26, 2024

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Humana Inc. Announces Management Changes

Humana Inc. to Report Q3, 2023 Results on Nov 01, 2023

Humana: Upgrade To Buy

Humana Inc. (NYSE:HUM) agreed to acquire Senior-focused primary care centers in Texas and Nevada of Cano Health, LLC for $66.7 million.

Humana: Buy This Amazing Wealth Compounder Now, You'll Be Glad You Did

Upcoming dividend of US$0.89 per share at 0.7% yield

Centerwell Senior Primary Care Introduces In-Home Primary Care

We Think Humana (NYSE:HUM) Can Manage Its Debt With Ease

Humana Inc. Declares Cash Dividend, Payable on October 27, 2023

Humana Inc. Revises Earnings Guidance for the Year Ending December 31, 2023

Humana: Mr. Market Got This One Right

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Humana: Recent Selloff Might Present A Buying Opportunity

Humana Inc. to Report Q2, 2023 Results on Aug 02, 2023

Humana: Rising Medical Costs Should Be Temporary

Upcoming dividend of US$0.89 per share at 0.8% yield

Humana: Margin Expansion Supported By Growing Memberships

Humana (NYSE:HUM) Seems To Use Debt Rather Sparingly

Chief Financial Officer recently sold US$415k worth of stock

Chief Financial Officer notifies of intention to sell stock

First quarter 2023 earnings: Revenues exceed analyst expectations

Humana Inc. (NYSE:HUM) Shares Could Be 49% Below Their Intrinsic Value Estimate

Upcoming dividend of US$0.89 per share at 0.7% yield

High number of new directors

President notifies of intention to sell stock

Humana Inc. Declares Cash Dividend, Payable on April 28, 2023

Full year 2022 earnings: EPS misses analyst expectations

Humana Inc. Provides Earnings Guidance for the Fiscal Year Ending December 31, 2023

Humana Q4 2022 Earnings Preview

Humana: Destined For A Long-Term Success

Humana (NYSE:HUM) Could Easily Take On More Debt

Humana Inc. to Report Q4, 2022 Results on Feb 01, 2023

Independent Director recently sold US$7.5m worth of stock

Humana receives $70.85B contract from Defense Health Agency

President exercised options and sold US$1.5m worth of stock

Are Investors Undervaluing Humana Inc. (NYSE:HUM) By 34%?